The status of estrogen receptor (ER), progesterone receptor (PR) and epidermal growth factor receptor 2 (HER2) detected by immunohistochemistry is used in the clinic to decide treatment strategy for breast cancer [2]. The gene discussed is PGR; the disease is breast cancer.